Century Therapeutics IPSC
NASDAQ IPSC
$1.58 -0.03 (-1.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Amortization of Deferred Charges (2020 - 2023)

Updated

Analysis

Century Therapeutics (IPSC) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.40 Bn 1,112.99 Bn 19.71 Bn
2 Johnson & Johnson 634.88 Bn 554.74 Bn 17.30 Bn
3 AbbVie 500.40 Bn 473.51 Bn 12.70 Bn
4 Merck 356.05 Bn 310.43 Bn 12.21 Bn
5 Novartis Ag 301.50 Bn 265.49 Bn 11.24 Bn
6 Astrazeneca 264.72 Bn 238.40 Bn 12.86 Bn
7 Amgen 238.14 Bn 193.54 Bn 7.24 Bn
8 Gilead Sciences 195.19 Bn 169.39 Bn 6.22 Bn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn
10 Century Therapeutics 311.55 Mn -192.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 38,000.00
Mar 31, 2023 56,000.00
Dec 31, 2022 69,000.00
Sep 30, 2022 77,000.00
Jun 30, 2022 76,000.00
Mar 31, 2022 76,000.00
Dec 31, 2021 77,000.00
Sep 30, 2021 77,000.00
Jun 30, 2021 76,000.00
Mar 31, 2021 75,000.00
Dec 31, 2020 78,000.00
Sep 30, 2020 14,000.00
API Access

Century Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IPSC&period=max&api_key=YOUR_API_KEY